top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advances and Novel Treatment Options in Metastatic Melanoma
Advances and Novel Treatment Options in Metastatic Melanoma
Autore Facchiano Antonio
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (528 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato ABT-737
acetazolamide
acetylcholine
adjuvant therapy
amoeboid motility
angiogenesis
apoptosis
arthralgia
Bcl-2 family
BCL2L10
biomarkers
BRAF
BRAF inhibitor
BRAF inhibitors
BRAF-mutant melanoma
cancer
cancer associated fibroblast
cancer stem cells
carbonic anhydrase
cell therapy
checkpoint inhibitor
cholinergic system
combined therapy
ctDNA
CXCL10
cyclopamine
cytokines
cytotoxicity
diagnosis
DOCK4
drug resistance
essential oils
exosomes
extracellular vesicles
FAK
hedgehog
HIPPO
HuR
immunity
immunotherapy
interferon
invasion
ipilimumab
lactate dehydrogenase
lipid metabolism
liquid biopsy
liver-directed-therapies
machine learning
MANS peptide
MARCKS
mechanism of action
melanoma
melanoma immune infiltrate
melanoma markers
melanoma metastasis
melanoma PDX
melanomagenesis
metalloproteinases
metastases
metastasis
metastatic dormancy
metastatic therapy
metastatic uveal melanoma (mUM)
microenvironment
microRNAs
MITF
ML258
motility
mucosal melanoma
muscarinic receptors
n/a
nanoparticles
nicotinic receptors
nivolumab
OXPHOS
patient stratification
PD-1
pembrolizumab
phosphorylation
plasmacytoid dendritic cells
prediction
principal component analysis
prognosis
prognostication
protein tyrosine phosphatase
PTPs inhibitors
Rac1
radiotherapy
resistance
rheumatoid arthritis
sex-hormones
sex/gender
ShcD adaptor protein
siRNA
slow cycling phenotype
small molecules
SOCE
STAT3
Support Vector Machine
survival
target therapy
targeted therapy
targeted-therapy
therapeutic resistance
therapy
TLR
TPC2
tumor microenvironment
tumour microenvironment
uveal melanoma (UM)
WNT5A
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557612103321
Facchiano Antonio  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Advances in epithelial ovarian cancer [[electronic resource] ] : model systems, microenvironmental influences, therapy, and origins / / edited by Viive Maarike Howell, Ben Davidson, Tian-Li Wang and Christina Annunziata
Advances in epithelial ovarian cancer [[electronic resource] ] : model systems, microenvironmental influences, therapy, and origins / / edited by Viive Maarike Howell, Ben Davidson, Tian-Li Wang and Christina Annunziata
Autore Ben Davidson
Pubbl/distr/stampa Frontiers Media SA, 2016
Descrizione fisica 1 online resource (176 pages) : illustrations; digital, PDF file(s)
Disciplina 616.99465
Collana Frontiers Research Topics
Frontiers in oncology
Soggetto topico Ovaries - Cancer - Research
Neoplasms
Oncology
Soggetto non controllato 3D-cell culture
Ovarian cancer stem cells
ovarian cancer
tumor-associated macrophage
BRCA
chemoresistance
fallopian tube
tumour microenvironment
mouse models of ovarian cancer
patient derived xenografts
primary ovarian tumour cells
Ascites
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910136793403321
Ben Davidson  
Frontiers Media SA, 2016
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Nanomedicine
Cancer Nanomedicine
Autore Hoskins Clare
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (510 p.)
Soggetto topico Technology: general issues
Soggetto non controllato actin
active targeting
acute toxicity
adsorption
albumin
albumin nanoparticle
albumin nanoparticles
anacardic acid
angiogenesis
anti-cancer
anti-metastatic enzyme cancer therapy
anti-topoisomerase activity
anti-tumor immunity
antibody drug conjugate (ADC)
anticancer and antibacterial activity
antitumor strategy
apoptosis
ascorbic acid
BALB-neuT mice
biodistribution
biomimetic
biomimetic core-shell nanoparticles
biomimicry
bleeding
blood brain barrier
brain tumours
breast cancer
cabazitaxel
cancer
cancer diagnosis
cancer nanomedicine
cancer therapy
cathepsin D
cathepsin L
cats
cell signaling
cellular interaction
cellular microenvironment
chemico-physical functionalization
chemotherapeutics
chirality separation
clinical status
clinical translation
collagen
colloidal stability
colorectal carcinoma
combinatorial therapy
copper
CPMV
CSCs
cyclodextrins
cytotoxicity
diagnostics
differentiated neuroblastoma
dioleoylphosphatidylethanolamine
DNA origami
docetaxel
dogs
DOX
doxorubicin
drug combination
drug delivery
drug delivery system
drug-gene delivery
drug-in-cyclodextrin-in-liposome
dual-targeting
epithelial-to-mesenchymal transition
EPR effect
erlotinib
everolimus
exosomes
extracellular vesicles
FA-DABA-SMA
flow
folate
folate receptor
folic receptor alpha
glioblastoma
glioma
gold nanoparticles
gold nanorods
graphene oxide
hepatocellular carcinoma
hyaluronic acid
hyaluronidase
hybrid nanoparticles
hyperthermia
hyperthermia therapy
hypoxia
imaging
immune modulation
immunosuppression
immunotherapy
Immunotherapy
in situ vaccine
in vitro
in vitro anti-cancer activity
integrin
intra-arterial chemotherapy
intracellular disruption
intracranial glioma
iron affinity
lanthanide metal
ligand
lipid nanoparticles
liposome
liposomes
loading
lung cancer
lymphadenectomy
magnetic actuation
magnetic drug targeting
magnetic hyperthermia
magnetic nanoparticles
magnetic nanowires
magnetic silica-coated iron oxide nanochains
magnetometer
mammary carcinoma
mangiferin
MDA-MB-231
melanoma
membrane-wrapped
mesenchymal stem cells (MSCs)
Mesoporous silica nanoparticle
mesoporous silica nanoparticles
metabolism
microbubble
microfluidic
mitoxantrone
mixed micelle
molecular imaging
monoclonal antibodies
multicellular tumor spheroids
nano-bio interactions
nano-engineered MSCs
nanobiotechnology
nanocarrier
nanomedicine
nanomedicines
nanomicelles
nanoparticle
nanoparticles
nanostructured lipid carrier
nanosystems
nanotechnology: bioengineering
nanotherapeutics
NASH
near IR hyperspectral imaging
NK cell-derived exosomes
oncogenes
oncogenic proteins
organoids
organotin
orthotopic lung tumor model
osteopontin
ovarian cancer
ovarian carcinomatosis
oxidation-sensitive release
paclitaxel
pancreatic cancer
parvifloron D
passive targeting
PD-L1
PEGylation
peptidomimetics
pH responsive
photodynamic therapy
photodynamic therapy article
photothermal therapy
photothermal treatment
plasmonic photothermal therapy
plasmonics
platelet membrane
PLGA
poly(hydroxyethyl acrylate-co-allyl methyl sulfide) copolymer
polydopamine nanoparticles
polymeric nanoconstruct
polymeric nanoparticles
prostate cancer
radiotherapy
real-time quantitative polymerase chain reaction (qPCR)
remote loading
RGD peptide
riboflavin
secondary structure
self-assembly
sentinel lymph node dissection
shear stress
single-walled carbon nanotubes
siRNA
size
SN38
spheroids
SPION
stimuli-responsive
superparamagnetic iron oxide nanoparticles
surgery
target treatment
targeted delivery
targeted delivery system
targeted drug delivery
targeted therapy
TAT peptide
temoporfin
theranostic nanomaterials
theranostics
therapeutics
titanate nanotubes
translational medicine
triple negative breast cancer
tumor microenvironment
tumor spheroid disruption
tumor targeting
tumor vectorization
tumour microenvironment
tumour targeting
ultrasound
vectorization
VEGF
verteporfin
viral nanoparticles
vitamin B2
VX2 tumor
Vδ2 T cells
yet reasonably common within the subject discipline
zoledronic acid
β-cyclodextrin nanosponges
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557114703321
Hoskins Clare  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cytobiology of Human Prostate Cancer Cells and Its Clinical Applications
Cytobiology of Human Prostate Cancer Cells and Its Clinical Applications
Autore Ishii Kenichiro
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (184 p.)
Soggetto topico Medicine
Soggetto non controllato abiraterone
AKR1C3
androgen deprivation therapy
androgen receptor
androgen receptor dependency
androgen sensitivity
animal model
apoptosis
autophagy
cabazitaxel
CAF
castration resistant prostate cancer
castration-resistant prostate cancer
Caveolin-1
CCL2
CCL22
CCL5
chemotherapy
CW069
cytokine
diet
docetaxel
docetaxel resistance
enzalutamide
EPI-002
epigenetics
fat
fibroblast
fibroblast growth factor
fibroblast growth factor receptor
fibroblast-dependent androgen receptor activation
fibroblasts
G1 cell cycle arrest
high-fat diet
hormone-naïve prostate cancer
immune cells
immunohistochemistry
in vitro
in vivo
inflammation
KIFC1
LSD1
migration
mouse
n/a
obesity
P-glycoprotein
pirfenidone
prostate cancer
prostate-specific antigen
radiotherapy
resistance
splice variant
testosterone
TGFβ1
time to PSA nadir
tissue microarray
TP53-regulated inhibitor of apoptosis 1
tumour microenvironment
tumour stroma
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557116703321
Ishii Kenichiro  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Novel Biomarkers of Gastrointestinal Cancer
Novel Biomarkers of Gastrointestinal Cancer
Autore Shimura Takaya
Pubbl/distr/stampa Basel, : MDPI Books, 2022
Descrizione fisica 1 electronic resource (248 p.)
Soggetto topico Medicine
Oncology
Soggetto non controllato colorectal cancer
advanced adenoma
screening
stool
mRNA
cancer screening
cirrhosis
AFP
machine learning
MALDI-TOF
proteomics
CXCR4
prognosis
overall survival
rectal cancer
neoadjuvant chemoradiation
mouse model
biomarkers
urokinase plasminogen activator (uPA)
urokinase plasminogen activator receptor (uPAR)
plasminogen activator inhibitor type 1 (PAI-1)
circulating tumour cell (CTC)
gastric cancer
oesophageal cancer
serine proteases
tumour microenvironment
serpins
biomarker
chemoresistance
liquid biopsy
microRNA
long non-coding RNA
colorectal neoplasms
cancer screening tests
early detection of cancer
precision medicine
unfolded protein
hepatocellular cancer
GSVA
unfolded protein score
epigenetic regulation genes
somatic mutations
molecular genetic markers
extracellular vesicles
microbiome
16S rRNA amplicon
metagenomics
liver fibrosis
hepatocellular carcinoma
recurrence
SHG/TPEF microscopy
artificial intelligence
advanced gastric cancer
targeted therapy
urinary miRNA
miR-129-1-3p
miR-566
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910595076103321
Shimura Takaya  
Basel, : MDPI Books, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Radiation Response Biomarkers for Individualised Cancer Treatments
Radiation Response Biomarkers for Individualised Cancer Treatments
Autore Badie Christophe
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (231 p.)
Soggetto topico Medicine
Soggetto non controllato abscopal effect
biodosimetry
biological dosimetry
biomarker
biomarkers
cancer
carbon-ion radiotherapy
cGAS
chromosomal instability
chromosome aberrations
circulating biomarkers
circulating tumour cells
clonogenic assays
dicentric assay
exosomes
extracellular vesicles
gamma H2AX foci assay
GC/MS
genotoxicity tests
head and neck cancer
head-and-neck tumors
health surveillance analyses
human blood
immune infiltrate
immune system
immunotherapy
IMRT
individual radiosensitivity
inflammation
inversions
ionizing radiation
late effects
liquid biopsy
lung cancer
machine learning
metabolomics
methods
micronuclei
micronucleus assay
microRNA
microRNAs
n/a
normal tissue
normal tissue toxicity
PBMCS
personalized medicine
plating
pneumonitis
predictive tests
prostate cancer
protein
proteomics
radiation
radiation-induced lung fibrosis
radiation-induced lung injury
radiosensitivity
radiotherapy
radiotherapy monitoring
relative biological effectiveness
RILF
RILI
serum
squamous cell carcinoma
STING
stroma
telomeres
tumour microenvironment
uterine cervical cancer
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557345403321
Badie Christophe  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
The Shaping of Cancer by the Tumour Microenvironment and Its Relevance for Cancer Therapy
The Shaping of Cancer by the Tumour Microenvironment and Its Relevance for Cancer Therapy
Autore Madureira Patrícia Alexandra Saraiva
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (307 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato 3D co-culture
biomarker
biomarkers
bladder cancer
breast cancer
cancer
cancer acidity
cancer cells subpopulations
cancer development
cancer recurrence
cancer stem cells
cancer-associated fibroblast (CAF)
carcinoma
chemotherapy response
clinical trials
colon cancer
cross-presentation
CTLA-4
cytokine/chemokine
darwinian evolution
diclofenac
evolutionary therapy
extracellular matrix (ECM)
feline mammary carcinoma
glioblastoma (GB)
glioma stem cells (GSC)
growth factors
head and neck cancer
histone modification
hyperosmolarity
hypoxia
Hypoxia Inducible Factor (HIF)
immune cell infiltration
immunomodulatory roles
immunotherapy
inhibitor
KDM5B
koningic acid
lung cancer
macrophages
mammary gland
metastasis
microenvironment
molecular docking
molecular subtypes of pancreatic cancer
myeloid cells
myeloid derived suppressor cells
myeloid-derived suppressor cells
oxidative stress
PAI-1
PAI-2
pancreatic stellate cells
PD-1
PD-L1
plasmin
plasminogen
pre-metastatic niche
preclinical modelling
pro- and anti-tumor immune cells
pro-inflammatory cytokines
prognosis
prostate cancer
radioresistance
radiosensitivity
radiotherapy
radiotherapy dose fractionation
reactive oxygen species
regulatory T cells
repurposing
resistance
S100A10
S100A10 (p11)
signaling pathways
spheroid
stroma
syngeneic model
targeted therapy
therapeutic resistance
TNF-α
triple negative
tumor growth
tumor microenvironment
tumor progression
tumor-associated macrophages
tumour microenvironment
uPA
uPAR
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557354203321
Madureira Patrícia Alexandra Saraiva  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui